You are here

Heska Corporation to Present at 2019 Canaccord Genuity Annual Growth Conference

LOVELAND, Colo., July 17, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the 2019 Canaccord Genuity Annual Growth Conference on Wednesday, August 7, 2019 at 8:30 a.m. ET at the InterContinental in Boston, MA.

Management will be available for one-on-one meetings on August 7th. To schedule a meeting, please contact Canaccord Genuity at or Heska Investor Relations at

A live webcast of the company's presentation can be accessed at The webcast will be archived after the event, and a replay will be available on the company's website for 90 days. A copy of the presentation will also be available at

For more information about the Canaccord Genuity Annual Growth Conference, please visit:

About Heska
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through two business segments; Core Companion Animal Health ("CCA") represents approximately 80% of revenues, and Other Vaccines and Pharmaceuticals ("OVP") segment represents approximately 20% of revenues. CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health. For further information on Heska and its products, visit


Cision View original content to download multimedia:

SOURCE Heska Corporation